Veteran's Prostate Cancer Treatment and Research Act
Do you support it?
Want to know if it passes?
We'll email you when HR 6092 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 6092.
You're tracking HR 6092
We'll email you the moment it moves.
HR 6092 — Veteran's Prostate Cancer Treatment and Research Act
Last action — Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer. Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment. The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually. Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation. Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 6092 on the official United States source →Action History
-
Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
-
Motion to reconsider laid on the table Agreed to without objection.
-
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4684-4685)
-
DEBATE - The House proceeded with forty minutes of debate on H.R. 6092.
-
Considered under suspension of the rules. (consideration: CR H4682-4685)
-
Mr. Takano moved to suspend the rules and pass the bill, as amended.
-
Ordered to be Reported by Voice Vote.
-
Committee Consideration and Mark-up Session Held.
-
Committee Hearings Held.
-
Referred to the House Committee on Veterans' Affairs.
-
Introduced in House
Sponsors
- Neal Dunn · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 6092 do?
- Requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer. Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment. The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually. Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation. Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.
- Who sponsors HR 6092?
- HR 6092 is sponsored by Neal Dunn (R).
- What is the current status of HR 6092?
- This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 6092?
- Track HR 6092 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 6092
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 6092
Last checked for changes about 13 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →